Neurological Symptoms in Coronavirus Disease 2019 Patients: An Updated Literature Review

  • Somayeh Mohammadi Department of Anesthesiology and Critical Care Medicine, Medical Center, University of Chicago, Chicago, IL, USA
  • Amirabbas Rostami Department of Internal Medicine, Faculty of General Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  • Fateme Naghdizadeh School of Nursing and Midwifery, Yasuj University of Medical Sciences, Yasuj, Iran
  • Mahdie ShojaeiBaghini Medical Informatics Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
  • Nooshin Karami Department of Clinical Psychology, Shiraz University of Education and Psychology, Shiraz, Iran
  • Sohrab Negargar Cardiovascular Research Center of Tabriz University of Medical Sciences, Tabriz, Iran
  • Mohsen Emadi Faculty of Humanities, Department of Sport Sciences, Jahrom University, Jahrom, Iran
  • Morteza Jafarinia Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Keywords: Alzheimer, SARS-CoV-2, Coronavirus Disease 2019, Epilepsy, Multiple Sclerosis, Parkinson

Abstract

Several studies have reported that coronavirus disease 2019 (COVID-19) can lead to multi-organ dysfunction. COVID-19 has been linked to a variety of neurological symptoms, according to the literature. The various paths via which the brain can be infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as the symptoms of COVID-19 in neurological diseases, are discussed. COVID-19 symptoms have been observed in neurological illnesses such as epilepsy, ischemic stroke, multiple sclerosis, Alzheimer's disease, subarachnoid hemorrhage, Guillain–Barré syndrome, and Parkinson's disease in several investigations.

References

Vakili S, Akbari H, Jamalnia S. Clinical and Laboratory findings on the differences between h1n1 influenza and coronavirus disease-2019 (covid-19): focusing on the treatment approach. Clin Pulm Med. 2020;27(4):87-93.

https://doi.org/10.1097/CPM.0000000000000362

Danesh H, Barzegar F, Maddahi F, Horri E, Abdolrazaghnejad A. Medical and Pharmacological Evaluation of Infection Control in Covid-19 Patients. J Med Chem Sci. 2022;5(2):257-69.

Vakili S, Savardashtaki A, Jamalnia S, Tabrizi R, Nematollahi MH, Jafarinia M, et al. Laboratory findings of COVID-19 infection are conflicting in different age groups and pregnant women: a literature review. Arch Med Res. 2020;51(7):603-7.

https://doi.org/10.1016/j.arcmed.2020.06.007

PMid:32571605 PMCid:PMC7287430

Bhattacharyya S, Dey K, Paul AR, Biswas R. A novel CFD analysis to minimize the spread of COVID-19 virus in hospital isolation room. Chaos Solitons Fractals. 2020;139:110294.

https://doi.org/10.1016/j.chaos.2020.110294

PMid:32963423 PMCid:PMC7498234

Khalifehzadeh-Esfahani Z, Fattahi S, Heidari Haratemeh Z, Jafarinia M. The Role of Immune Regulatory Molecules in COVID-19. Viral Immunol. 2020;35(5):359-64.

https://doi.org/10.1089/vim.2021.0211

PMid:35443826

Gharayagh-Zandi D, Makouee S. COVID-19 and International Organizations: A Case Study of WHO. Int J Adv Stu Hum Soc Sci. 2022;11(1):1-20.

Harismah K, Mirzaei M. Favipiravir: structural analysis and activity against COVID-19. Adv J Chem B. 2020;2(2):55-60.

Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259-64.

https://doi.org/10.1038/s41586-021-03553-9

PMid:33887749

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.

https://doi.org/10.1016/S0140-6736(20)30183-5

PMid:31986264

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-90.

https://doi.org/10.1001/jamaneurol.2020.1127

PMid:32275288 PMCid:PMC7149362

Varatharaj A, Thomas N, Ellul MA, Davies NW, Pollak TA, Tenorio EL, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiat. 2020;7(10):875-82.

https://doi.org/10.1016/S2215-0366(20)30287-X

PMid:32593341

Taebi M, Tajik A, Zarepur A, Zarepur E, Tavakolimoghadam R, Danesh H. Rhabdomyolysis in Severe Covid19: A Mini Review Study. J Med Chem Sci. 2022:82-8.

Van den Pol AN. Viral infection leading to brain dysfunction: more prevalent than appreciated? Neuron. 2009;64(1):17-20.

https://doi.org/10.1016/j.neuron.2009.09.023

PMid:19840542 PMCid:PMC2782954

Bradshaw MJ, Venkatesan A. Herpes simplex virus-1 encephalitis in adults: pathophysiology, diagnosis, and management. Neurotherapeutics. 2016;13(3):493-508.

https://doi.org/10.1007/s13311-016-0433-7

PMid:27106239 PMCid:PMC4965403

Fattahi S, Khalifehzadeh-Esfahani Z, Mohammad-Rezaei M, Mafi S, Jafarinia M. PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy. Immunol Res. 2022:1-7.

https://doi.org/10.1007/s12026-022-09268-x

PMid:35107743 PMCid:PMC8808470

Jonny J, Violetta L. Coupled Plasma Filtration Adsorption as a Potential Therapy for Critically III Covid-19 Patients. J Med Chem Sci. 2022:197-203.

Matoba Y, Abiko C, Ikeda T, Aoki Y, Suzuki Y, Yahagi K, et al. Detection of the human coronavirus 229E, HKU1, NL63, and OC43 between 2010 and 2013 in Yamagata, Japan. Jpn J Infect Dis. 2015;68(2):138-41.

https://doi.org/10.7883/yoken.JJID.2014.266

PMid:25420656

Ye Z-W, Yuan S, Yuen K-S, Fung S-Y, Chan C-P, Jin D-Y. Zoonotic origins of human coronaviruses. Int J Biol Sci. 2020;16(10):1686.

https://doi.org/10.7150/ijbs.45472

PMid:32226286 PMCid:PMC7098031

Tse GM, To K, Chan PK, Lo A, Ng K, Wu A, et al. Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). J Clin Pathol. 2004;57(3):260-5.

https://doi.org/10.1136/jcp.2003.013276

PMid:14990596 PMCid:PMC1770245

Widagdo W, Raj VS, Schipper D, Kolijn K, Van Leenders GJ, Bosch BJ, et al. Differential expression of the Middle East respiratory syndrome coronavirus receptor in the upper respiratory tracts of humans and dromedary camels. J Virol. 2016;90(9):4838-42.

https://doi.org/10.1128/JVI.02994-15

PMid:26889022 PMCid:PMC4836314

Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581(7809):465-9.

https://doi.org/10.1038/s41586-020-2196-x

PMid:32235945

Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581(7807):215-20.

https://doi.org/10.1038/s41586-020-2180-5

PMid:32225176

Javadi M. Numerical calculation of necessary distancing regarding SARS-CoV-2 (COVID-19) vs. spherical viruses, based on environmental features. Eurasian Chem Commun. 2021:406-17.

Ara I, Maqbool M, Zehravi M, Gani I. Herbs Boosting Immunity in Covid-19: An Overview. Adv J Chem B. 2020;3(3):289-94.

Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020;14(2):185-92.

https://doi.org/10.1007/s11684-020-0754-0

PMid:32170560 PMCid:PMC7088738

Li M-Y, Li L, Zhang Y, Wang X-S. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9(02):23-9.

https://doi.org/10.1186/s40249-020-00662-x

PMid:32345362 PMCid:PMC7186534

Briguglio M, Bona A, Porta M, Dell'Osso B, Pregliasco FE, Banfi G. Disentangling the hypothesis of host dysosmia and SARS-CoV-2: the bait symptom that hides neglected neurophysiological routes. Front Physiol. 2020;11:671.

https://doi.org/10.3389/fphys.2020.00671

PMid:32581854 PMCid:PMC7292028

Eliezer M, Hautefort C, Hamel A-L, Verillaud B, Herman P, Houdart E, et al. Sudden and complete olfactory loss of function as a possible symptom of COVID-19. JAMA Otolaryngol Head Neck Surg. 2020;146(7):674-5.

https://doi.org/10.1001/jamaoto.2020.0832

PMid:32267483

Baig AM. Neurological manifestations in COVID‐19 caused by SARS‐CoV‐2. CNS Neurosci Ther. 2020;26(5):499.

https://doi.org/10.1111/cns.13372

PMid:32266761 PMCid:PMC7163592

Dahm T, Rudolph H, Schwerk C, Schroten H, Tenenbaum T. Neuroinvasion and inflammation in viral central nervous system infections. Mediators Inflamm. 2016;2016:8562805.

https://doi.org/10.1155/2016/8562805

PMid:27313404 PMCid:PMC4897715

Tu H, Tu S, Gao S, Shao A, Sheng J. Current epidemiological and clinical features of COVID-19; a global perspective from China. J Infect. 2020;81(1):1-9.

https://doi.org/10.1016/j.jinf.2020.04.011

PMid:32315723 PMCid:PMC7166041

Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033-4.

https://doi.org/10.1016/S0140-6736(20)30628-0

PMid:32192578

Tveito K. Cytokine storms in COVID-19 cases? Tidsskr Nor Laegeforen. 2020;140.

https://doi.org/10.4045/tidsskr.20.0239

Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623.

https://doi.org/10.1016/j.tmaid.2020.101623

PMid:32179124 PMCid:PMC7102608

Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures. J Med Virol. 2020;92(6):568-76.

https://doi.org/10.1002/jmv.25748

PMid:32134116 PMCid:PMC7228347

Espinosa PS, Rizvi Z, Sharma P, Hindi F, Filatov A. Neurological complications of coronavirus disease (COVID-19): encephalopathy, MRI brain and cerebrospinal fluid findings: case 2. Cureus. 2020;12(5).

https://doi.org/10.7759/cureus.7930

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13.

https://doi.org/10.1016/S0140-6736(20)30211-7

PMid:32007143

Sharifi-Razavi A, Karimi N, Rouhani N. COVID-19 and intracerebral haemorrhage: causative or coincidental? New Microbes New Infect. 2020;35:100669.

https://doi.org/10.1016/j.nmni.2020.100669

PMid:32322398 PMCid:PMC7163302

Wang L, He W, Yu X, Hu D, Bao M, Liu H, et al. Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020;80(6):639-45.

https://doi.org/10.1016/j.jinf.2020.03.019

PMid:32240670 PMCid:PMC7118526

Morelli N, Rota E, Terracciano C, Immovilli P, Spallazzi M, Colombi D, et al. The baffling case of ischemic stroke disappearance from the casualty department in the COVID-19 era. Eur Neurol. 2020:1.

https://doi.org/10.1159/000507666

PMid:32289789 PMCid:PMC7179532

Violi F, Pastori D, Cangemi R, Pignatelli P, Loffredo L. Hypercoagulation and antithrombotic treatment in coronavirus 2019: a new challenge. Thromb Haemost. 2020;120(6):949-56.

https://doi.org/10.1055/s-0040-1710317

PMid:32349133 PMCid:PMC7295290

McAbee GN, Brosgol Y, Pavlakis S, Agha R, Gaffoor M. Encephalitis associated with COVID-19 infection in an 11-year-old child. Pediatr Neurol. 2020;109:94.

https://doi.org/10.1016/j.pediatrneurol.2020.04.013

PMid:32586676 PMCid:PMC7180343

Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and ageusia: common findings in COVID‐19 patients. Laryngoscope. 2020;130(7):1787.

https://doi.org/10.1002/lary.28692

PMid:32237238 PMCid:PMC7228304

Gane SB, Kelly C, Hopkins C. Isolated sudden onset anosmia in COVID-19 infection A novel syndrome. Rhinology. 2020;58(3):299-301.

https://doi.org/10.4193/Rhin20.114

PMid:32240279

Ovesen T. COVID-19 anosmia. Tidsskr Nor Laegeforen. 2020;140(7).

https://doi.org/10.4045/tidsskr.20.0302

Xydakis MS, Dehgani-Mobaraki P, Holbrook EH, Geisthoff UW, Bauer C, Hautefort C, et al. Smell and taste dysfunction in patients with COVID-19. Lancet Infect Dis. 2020;20(9):1015-6.

https://doi.org/10.1016/S1473-3099(20)30293-0

PMid:32304629

Moein ST, Hashemian SM, Mansourafshar B, Khorram-Tousi A, Tabarsi P, Doty RL. Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 2020;10(8):944-50.

https://doi.org/10.1002/alr.22587

PMid:32301284 PMCid:PMC7262123

Villalba NL, Maouche Y, Ortiz MBA, Sosa ZC, Chahbazian JB, Syrovatkova A, et al. Anosmia and dysgeusia in the absence of other respiratory diseases: should COVID-19 infection be considered? Eur J Case Rep Intern Med. 2020;7(4).

Stafstrom CE, Carmant L. Seizures and epilepsy: an overview for neuroscientists. Cold Spring Harb Perspect. 2015;5(6):a022426.

https://doi.org/10.1101/cshperspect.a022426

PMid:26033084 PMCid:PMC4448698

Scharfman HE. The neurobiology of epilepsy. Curr Neurol Neurosci Rep. 2007;7(4):348-54.

https://doi.org/10.1007/s11910-007-0053-z

PMid:17618543 PMCid:PMC2492886

Sirven JI. Epilepsy: a spectrum disorder. Cold Spring Harb Perspect. 2015;5(9):a022848.

https://doi.org/10.1101/cshperspect.a022848

PMid:26328931 PMCid:PMC4561391

Vollono C, Rollo E, Romozzi M, Frisullo G, Servidei S, Borghetti A, et al. Focal status epilepticus as unique clinical feature of COVID-19: a case report. Seizure. 2020;78:109-12.

https://doi.org/10.1016/j.seizure.2020.04.009

PMid:32344366 PMCid:PMC7172719

Karimi N, Razavi AS, Rouhani N. Frequent convulsive seizures in an adult patient with COVID-19: a case report. Iran Red Crescent Med J. 2020;22(3).

https://doi.org/10.5812/ircmj.102828

Hepburn M, Mullaguri N, George P, Hantus S, Punia V, Bhimraj A, et al. Acute symptomatic seizures in critically ill patients with COVID-19: is there an association? Neurocrit Care. 2021;34(1):139-43.

https://doi.org/10.1007/s12028-020-01006-1

PMid:32462412 PMCid:PMC7253233

Lyons S, O'Kelly B, Woods S, Rowan C, Brady D, Sheehan G, et al. Seizure with CSF lymphocytosis as a presenting feature of COVID-19 in an otherwise healthy young man. Seizure-Eur J Epilep. 2020;80:113-4.

https://doi.org/10.1016/j.seizure.2020.06.010

PMid:32563170 PMCid:PMC7278645

Kadono Y, Nakamura Y, Ogawa Y, Yamamoto S, Kajikawa R, Nakajima Y, et al. A case of COVID-19 infection presenting with a seizure following severe brain edema. Seizure-Eur J Epilep. 2020;80:53-5.

https://doi.org/10.1016/j.seizure.2020.06.015

PMid:32540636 PMCid:PMC7282752

Anand P, Al-Faraj A, Sader E, Dashkoff J, Abdennadher M, Murugesan R, et al. Seizure as the presenting symptom of COVID-19: a retrospective case series. Epilepsy Behav. 2020;112:107335.

https://doi.org/10.1016/j.yebeh.2020.107335

PMid:32739397 PMCid:PMC7373049

Asadi-Pooya AA. Seizures associated with coronavirus infections. Seizure. 2020;79:49-52.

https://doi.org/10.1016/j.seizure.2020.05.005

PMid:32416567 PMCid:PMC7212943

Libbey JE, Fujinami RS. Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus. Future Virol. 2011;6(11):1339-50.

https://doi.org/10.2217/fvl.11.107

PMid:22267964 PMCid:PMC3259611

Singhi P. Infectious causes of seizures and epilepsy in the developing world. Dev Med Child Neurol. 2011;53(7):600-9.

https://doi.org/10.1111/j.1469-8749.2011.03928.x

PMid:21518343

Ying W, Qian Y, Kun Z. Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic. Res Social Adm Pharm. 2021;17(1):1978-83.

https://doi.org/10.1016/j.sapharm.2020.04.001

PMid:32317153 PMCid:PMC7136878

Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors J, Culebras A, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(7):2064-89.

https://doi.org/10.1161/STR.0b013e318296aeca

PMid:23652265

Hui C, Tadi P, Patti L. Ischemic Stroke. StatPearls. Treasure Island, FL: StatPearls Publishing; 2020.

Zhai P, Ding Y, Li Y. The impact of COVID-19 on ischemic stroke. Diagn Pathol. 2020;15(1):1-5.

https://doi.org/10.1186/s13000-020-00994-0

PMid:32600350 PMCid:PMC7323364

Avula A, Nalleballe K, Narula N, Sapozhnikov S, Dandu V, Toom S, et al. COVID-19 presenting as stroke. Brain Behav Immun. 2020;87:115-9.

https://doi.org/10.1016/j.bbi.2020.04.077

PMid:32360439 PMCid:PMC7187846

Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020;91(8):889-91.

https://doi.org/10.1136/jnnp-2020-323586

PMid:32354768 PMCid:PMC7231545

Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020;382(20):e60.

https://doi.org/10.1056/NEJMc2009787

PMid:32343504 PMCid:PMC7207073

Jain R, Young M, Dogra S, Kennedy H, Nguyen V, Jones S, et al. COVID-19 related neuroimaging findings: a signal of thromboembolic complications and a strong prognostic marker of poor patient outcome. J Neurol Sci. 2020;414:116923.

https://doi.org/10.1016/j.jns.2020.116923

PMid:32447193 PMCid:PMC7236667

Basi S, Hamdan M, Punekar S. Clinical course of a 66-year-old man with an acute ischaemic stroke in the setting of a COVID-19 infection. BMJ Case Rep. 2020;13(8):e235920.

https://doi.org/10.1136/bcr-2020-235920

PMid:32843381 PMCid:PMC7447108

Diaz-Segarra N, Edmond A, Kunac A, Yonclas P. COVID-19 ischemic strokes as an emerging rehabilitation population: a case series. Am J Phys Med Rehabil. 2020.

https://doi.org/10.1097/PHM.0000000000001532

PMid:32675706 PMCid:PMC7406213

Tafti D, Ehsan M, Xixis KL. Multiple Sclerosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.

Willis M, Robertson N. Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2. J Neurol. 2020;267(5):1567-9.

https://doi.org/10.1007/s00415-020-09822-3

PMid:32303837 PMCid:PMC7163169

Winkelmann A, Loebermann M, Reisinger EC, Hartung H-P, Zettl UK. Disease-modifying therapies and infectious risks in multiple sclerosis. Nat Rev Neurol. 2016;12(4):217-33.

https://doi.org/10.1038/nrneurol.2016.21

PMid:26943779

Crescenzo F, Marastoni D, Bovo C, Calabrese M. Frequency and severity of COVID-19 in multiple sclerosis: a short single-site report from northern Italy. Mult Scler Relat Disord. 2020;44:102372.

https://doi.org/10.1016/j.msard.2020.102372

PMid:32650121 PMCid:PMC7335234

Fan M, Qiu W, Bu B, Xu Y, Yang H, Huang D, et al. Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders. Neurol Neuroimmunol. 2020;7(5):e787.

https://doi.org/10.1212/NXI.0000000000000787

PMid:32503092 PMCid:PMC7286663

Louapre C, Collongues N, Stankoff B, Giannesini C, Papeix C, Bensa C, et al. Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis. JAMA Neurol. 2020;77(9):1079-88.

https://doi.org/10.1001/jamaneurol.2020.2581

PMid:32589189 PMCid:PMC7320356

Ferini-Strambi L, Salsone M. COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? J Neurol. 2021;268(2):409-19.

https://doi.org/10.1007/s00415-020-10070-8

PMid:32696341 PMCid:PMC7372546

Sadeghmousavi S, Rezaei N. COVID-19 and multiple sclerosis: predisposition and precautions in treatment. SN Compr Clin Med. 2020;2(10):1802-7.

https://doi.org/10.1007/s42399-020-00504-9

PMid:32895640 PMCid:PMC7467844

Buljevac D, Flach H, Hop W, Hijdra D, Laman J, Savelkoul H, et al. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain. 2002;125(5):952-60.

https://doi.org/10.1093/brain/awf098

PMid:11960885

Correale J, Fiol M, Gilmore W. The risk of relapses in multiple sclerosis during systemic infections. Neurology. 2006;67(4):652-9.

https://doi.org/10.1212/01.wnl.0000233834.09743.3b

PMid:16870812

Palao M, Fernández-Díaz E, Gracia-Gil J, Romero-Sánchez C, Díaz-Maroto I, Segura T. Multiple sclerosis following SARS-CoV-2 infection. Mult Scler Relat Disord. 2020;45:102377.

https://doi.org/10.1016/j.msard.2020.102377

PMid:32698095 PMCid:PMC7340057

Ayton S, Lei P, Bush AI. Metallostasis in Alzheimer's disease. Free Radic Biol Med. 2013;62:76-89.

https://doi.org/10.1016/j.freeradbiomed.2012.10.558

PMid:23142767

Bianchetti A, Rozzini R, Guerini F, Boffelli S, Ranieri P, Minelli G, et al. Clinical presentation of COVID19 in dementia patients. J Nutr Health Aging. 2020;24(6):560-2.

https://doi.org/10.1007/s12603-020-1389-1

PMid:32510106 PMCid:PMC7227170

Fotuhi M, Mian A, Meysami S, Raji CA. Neurobiology of COVID-19. J Alzheimer's Dis. 2020;76(1):3-19.

https://doi.org/10.3233/JAD-200581

PMid:32538857 PMCid:PMC7660990

Naughton SX, Raval U, Pasinetti GM. Potential novel role of COVID-19 in Alzheimer's disease and preventative mitigation strategies. J Alzheimer's Dis. 2020;76(1):21-5.

https://doi.org/10.3233/JAD-200537

PMid:32538855 PMCid:PMC8057202

Roy ER, Wang B, Wan Y-w, Chiu G, Cole A, Yin Z, et al. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J Clin Investig. 2020;130(4):1912-30.

https://doi.org/10.1172/JCI133737

PMid:31917687 PMCid:PMC7108898

Tysnes O-B, Storstein A. Epidemiology of Parkinson's disease. J Neural Transm. 2017;124(8):901-5.

https://doi.org/10.1007/s00702-017-1686-y

PMid:28150045

Del Prete E, Francesconi A, Palermo G, Mazzucchi S, Frosini D, Morganti R, et al. Prevalence and impact of COVID-19 in Parkinson's disease: evidence from a multi-center survey in Tuscany region. J Neurol. 2021;268(4):1179-87.

https://doi.org/10.1007/s00415-020-10002-6

PMid:32880722 PMCid:PMC7471534

Fasano A, Elia AE, Dallocchio C, Canesi M, Alimonti D, Sorbera C, et al. Predictors of COVID-19 outcome in Parkinson's disease. Parkinsonism Relat Disord. 2020;78:134-7.

https://doi.org/10.1016/j.parkreldis.2020.08.012

PMid:32827969 PMCid:PMC7424315

Fasano A, Cereda E, Barichella M, Cassani E, Ferri V, Zecchinelli AL, et al. COVID‐19 in Parkinson's disease patients living in Lombardy, Italy. Mov Disord. 2020;35(7):1089-93.

https://doi.org/10.1002/mds.28176

PMid:32484584 PMCid:PMC7300944

Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383-4.

https://doi.org/10.1016/S1474-4422(20)30109-5

PMid:32246917

Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574-6.

https://doi.org/10.1056/NEJMc2009191

PMid:32302082 PMCid:PMC7182017

Finsterer J, Scorza FA, Ghosh R. COVID‐19 polyradiculitis in 24 patients without SARS‐CoV‐2 in the cerebro‐spinal fluid. J Med Virol. 2020;93(1):66-8.

https://doi.org/10.1002/jmv.26121

PMid:32497288 PMCid:PMC7300798

Su XW, Palka SV, Rao RR, Chen FS, Brackney CR, Cambi F. SARS-CoV-2-associated Guillain-Barré syndrome with dysautonomia. Muscle Nerve. 2020;62(2):E48-9.

https://doi.org/10.1002/mus.26988

PMid:32445201 PMCid:PMC7283744

Assini A, Benedetti L, Di Maio S, Schirinzi E, Del Sette M. New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases. Neurol Sci. 2020;41(7):1657-8.

https://doi.org/10.1007/s10072-020-04484-5

PMid:32468450 PMCid:PMC8849645

Ziu E, Khan Suheb MZ, Mesfin FB. Subarachnoid Hemorrhage. In Treasure Island (FL). StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441958/.

Craen A, Logan G, Ganti L. Novel coronavirus disease 2019 and subarachnoid hemorrhage: a case report. Cureus. 2020;12(4).

https://doi.org/10.7759/cureus.7846

PMid:32483497 PMCid:PMC7253081

Al Saiegh F, Ghosh R, Leibold A, Avery MB, Schmidt RF, Theofanis T, et al. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J Neurol Neurosurg Psychiatry. 2020;91(8):846-8.

https://doi.org/10.1136/jnnp-2020-323522

PMid:32354770

Published
2022-11-23
How to Cite
Mohammadi, S., Rostami, A., Naghdizadeh, F., ShojaeiBaghini, M., Karami, N., Negargar, S., Emadi, M., & Jafarinia, M. (2022). Neurological Symptoms in Coronavirus Disease 2019 Patients: An Updated Literature Review. Galen Medical Journal, 11, e2539. https://doi.org/10.31661/gmj.v11i.2539